Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C59 - COVID-19 and Neuromuscular Disorders

Sunday 04/03/22
03:30 PM - 05:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Pushpa Narayanaswami, MBBS, MD, FAAN
Infectious Disease, Neuromuscular and Clinical Neurophysiology (EMG)
Participants should be able to: Discuss the effects of infections, including COVID-19, on patients with underlying neuromuscular diseases (NMD) and identify NMDs associated with preceding infections; List the available COVID-19 vaccines, identify their mechanisms of action and describe the effectiveness and adverse effects of these vaccines to apply to clinical practice; Create a plan for infection prevention in patients with NMD including monitoring, prophylaxis and immunization.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student
Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM PDT Introduction Course Overview
Pushpa Narayanaswami, MBBS, MD, FAAN
03:30 PM - 03:30 PM PDT Speaker walk in slides
Pushpa Narayanaswami, MBBS, MD, FAAN
03:35 PM - 04:10 PM PDT Speaker Infections and Neuromuscular Disorders
Gregory Gruener, MD
04:10 PM - 04:45 PM PDT Speaker Efficacy and Safety of SARS CoV-2 Vaccines
Pushpa Narayanaswami, MBBS, MD, FAAN
04:45 PM - 05:20 PM PDT Speaker Infection Prevention in Neuromuscular Disorders
Sasha Zivkovic, MD, FAAN
05:20 PM - 05:30 PM PDT Q&A Questions and Answers
Pushpa Narayanaswami, MBBS, MD, FAAN, Sasha Zivkovic, MD, FAAN, Gregory Gruener, MD
Faculty Disclosures
Pushpa Narayanaswami, MBBS, MD, FAAN Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has stock in Moderna. Dr. Narayanaswami has stock in Dr. Reddys laboratories. Dr. Narayanaswami has stock in Pfizer. Dr. Narayanaswami has stock in Viatris. Dr. Narayanaswami has stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. Dr. Narayanaswami has a non-compensated relationship as a Member, Medical and Scientific Advisory Board with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Narayanaswami has a non-compensated relationship as a Member, Board of Directors with AANEM that is relevant to AAN interests or activities.
Sasha Zivkovic, MD, FAAN Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Zivkovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam .
Gregory Gruener, MD Dr. Gruener has nothing to disclose.